Societe Generale Effekten (S29343) Cotización

So far, dumbest post of the day. The delay is due to a screwed up submission by Linda Worthless that they will not talk about thus the mute silence from the worlds worst ceo. You paid pumpers sure come up with some not creative fiction to explain the faults of nonmanagement. Grow a pair or rent some

Alan Jackson - I Want To Stroll Over Heaven With You
[yt]x-8iDUK2V8Q[/yt]

so fsr today?

Since the debt pay off was on the last annual posted in the fall of 2023 and the dilution occurred after that ( didn't it begin showing up on OTC markets in December 2023), is it possible the amount of shares diluted was to reimburse the money Loyal paid out?

After all, mute, inept and full of GRIFT is the nwbo MO.

SunHydrogen Achieves Highest Known Efficiency for a Large-Area Hydrogen Module
Press Release | 02/05/2025
CORALVILLE, IA , Feb. 05, 2025 (GLOBE NEWSWIRE) -- SunHydrogen, Inc. (OTCQB: HYSR), the developer of a breakthrough technology to produce renewable hydrogen using sunlight and wate

It's where the dummies congregate.

Looking at a 5 year chart of this stock it looks like a bear etf.

"With our global patents and pending patents, we are revolutionizing environmental solutions for a sustainable future." https://thesustainablegreenteam.com/sgtm-home-page

Dream on, this will never ever happen.

https://investorshub.advfn.com/uimage/uploads/2025/2/5/nxjmuIMG_2977.jpeg

Blame them for what? The ‘delay’ in a process that varies wildly in scope and complexity and was never assigned a deadline in the first place? I imagine the MAA is at least as complicated as building a house. How often does that happen ‘on time’? The company doesn’t update so as to avoid the kind of

• Drugs appearing on this list are typically those that are already approved or are expected to receive regulatory approval soon.
...
• If Mircidencel is still in the regulatory approval process, its inclusion in NHS documentation could indicate that approval is anticipated.
...

Barbara Fiacco is a lawyer representing Enanta, correct? CORRECT!
She has represented leading pharmaceutical and life sciences clients in significant patent infringement lawsuits that have resulted in summary judgment or other favorable outcomes for her clients.

Also,
D

short volume percentage
10.61% 2-4-25

OTCShortReport.com

DBMM

********** NEW! **********

LOXAPINE SUCCINATE
ANDA #076868 SUPPL-12
ELITE LABS INC
Status: Labeling Approval

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=076868

Should see the 60's! core holding in my IRA was $7.00 not that long ago need the foresight to really hit these home runs!

They have a new post on x about this deal they're announcing I left a comment about the dilution happening

It needs a good catalyst. One with substance, and no fluff

Thank you for your reply.

style="caret-color: rgb(34, 34, 34); color: rgba(34, 34, 34, 1); font-family: Roboto, "Helvetica Neue", Helvetica, Arial, sans-serif; background-color: rgba(255, 255, 255, 1)""Critical projects in Alaska like Ambler Road and Pebble Mine and oil and gas exploration in ANWR which are held up by radica

Deepseek is lying and used 5k H-100

Fat synthesizer oral drug best in class SGMT Break through designation can apply for approval with Phase 3 after 1 year if the data follows their phase2b readout. Tam for Mash and Obesity will be over a quarter trillion in the coming years.


Pediatric Nash for SGMT i Pediatr

The exciting deal should see this hit .0006 and then collapse to .0003